“…The building of cyclic nucleotides is influenced by several hormones or neurotransmitters and the degradation of cyclic nucleotides can also be regulated by such substances (Loten et al, 1978;Saeed et al, 1981;Nemoz & Prigent, 1984;Keppens & de Wulf, 1984;Vallet-Strouve et al, 1984;Conti et al, 1984;Teo et al, 1987;Saltiel & Steigerwalt, 1986;Nagasaka et al, 1986;Francis & Kona, 1982). Further possibilities for the regulation of cyclic nucleotide phosphodiesterases are by the regulation of cyclic nucleotides themselves (Marchmont & Houslay, 1980;Martins et al, 1982;Palmer & Doukas, 1984;Tremblay et al, 1985), regulation by nucleotide binding proteins (De Mazancourt & Giudicelli, 1984), regulation of cyclic nucleotide phosphodiesterase by proteolysis (Sakai et al, 1977(Sakai et al, , 1978Epstein et al, 1978;Kincaid et al, 1985) and regulation by calcium/calmodulin (Thompson & Appleman, 1971;Ho et al, 1976;Sakai et al, 1977;Sharma & Wang, 1986;Grab et al, 1981;Erneux et al, 1985). Four major phosphodiesterase isoenzymes have been described (Hidaka et al, 1977;Manganiello et al, 1984;Reeves et al, 1987;Vaughan et al, 1980) which may exist in further multiple forms (Minneman, 1976;Pichard & Cheung, 1976;Hidaka et al, 1984;Erneux et al, 1985;Weishaar et al, 1985).…”